Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.32 USD | -7.34% | -17.19% | -6.51% |
30/05 | Canaccord Genuity Initiates TriSalus Life Sciences at Buy Rating With $12 Price Target | MT |
30/05 | Canaccord Genuity Starts Coverage on TriSalus Life Sciences With Buy Rating, $12 Price Target | MT |
Chart: Technical Analysis
- Stock Market
- Equities
- TLSI Stock
- Charts TriSalus Life Sciences, Inc.